These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21021618)

  • 21. Real-time measurement of free thrombin: evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation.
    Krajewski S; Krauss S; Kurz J; Neumann B; Schlensak C; Wendel HP
    Thromb Res; 2014 Mar; 133(3):455-63. PubMed ID: 24359968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Behavior of coagulation time of blood in normal and pathological subjects following intravenous administration of heparin (De Takats test)].
    DOTTI F; BONORA G
    Rass Int Clin Ter; 1950 Jun; 30(12):364-5. PubMed ID: 14781388
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of intramuscular injections of heparin on the blood clotting time and bleeding time of chickens.
    HUMBLE RJ; GLOVER JS
    Can J Comp Med Vet Sci; 1950 Apr; 14(4):162-5. PubMed ID: 15411610
    [No Abstract]   [Full Text] [Related]  

  • 24. [SOME INDICES OF THE BLOOD COAGULATION SYSTEM IN CORONARY DISORDERS IN ANIMALS].
    KAPLUN SIa; PAVLIK VA; KOPTEVA EG
    Farmakol Toksikol; 1964; 27():573-4. PubMed ID: 14264105
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel HIT antibody detection method using Sonoclot® coagulation analyzer.
    Wanaka K; Asada R; Miyashita K; Kaneko M; Endo H; Yatomi Y
    Thromb Res; 2015 Jan; 135(1):127-9. PubMed ID: 25466847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.
    Benedict CR; Ryan J; Wolitzky B; Ramos R; Gerlach M; Tijburg P; Stern D
    J Clin Invest; 1991 Nov; 88(5):1760-5. PubMed ID: 1939660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between heparin dosage and clotting time.
    JAQUES LB; RICKER AG
    Blood; 1948 Oct; 3(10):1197-1212. PubMed ID: 18884684
    [No Abstract]   [Full Text] [Related]  

  • 28. INCREASED SENSITIVITY TO HEPARIN FOLLOWING ACUTE MYOCARDIAL INFARCTION.
    DUFAULT C
    Can Med Assoc J; 1965 Jan; 92(1):13-5. PubMed ID: 14216140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin in blood clotting and thrombosis.
    BEST CH; JAQUES LB
    Ann N Y Acad Sci; 1948 May; 49(Art 4):501-17. PubMed ID: 18915056
    [No Abstract]   [Full Text] [Related]  

  • 30. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative inability of heparin to prolong clotting time of oxalated and resin-treated blood and plasma.
    SALOMON L; STEFANINI M
    Proc Soc Exp Biol Med; 1953 Nov; 84(2):476-8. PubMed ID: 13121078
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of the status of the anticoagulative system of blood in ischemic heart disease based on the calculation of the reserve of blood intracellular heparin].
    Gabitov SZ; Salikhov IG; Iunusov RV
    Kardiologiia; 1990 Jan; 30(1):85-7. PubMed ID: 2335872
    [No Abstract]   [Full Text] [Related]  

  • 33. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research review: use of activated clotting time to monitor heparin therapy in coronary patients.
    Noureddine SN
    Am J Crit Care; 1995 Jul; 4(4):272-7; quiz 278-9. PubMed ID: 7663590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of temperature upon the heparin and citrate clotting times.
    LOSNER S; VOLK BW
    Am J Med Sci; 1953 Jul; 226(1):60-4. PubMed ID: 13065283
    [No Abstract]   [Full Text] [Related]  

  • 36. [Waugh and Ruddick's heparin tolerance test in vitro in cholemic states].
    GIACCA S
    Arch Sci Med (Torino); 1953 Apr; 95(4):352-9. PubMed ID: 13081389
    [No Abstract]   [Full Text] [Related]  

  • 37. Clotting in heart and brain; experimental study.
    TRETHEWIE ER
    Aust J Exp Biol Med Sci; 1946 Sep; 24(3):185-90. PubMed ID: 20273973
    [No Abstract]   [Full Text] [Related]  

  • 38. Heparin monitoring in the coronary care unit after percutaneous transluminal coronary angioplasty.
    Varah N; Smith J; Baugh RF
    Heart Lung; 1990 May; 19(3):265-70. PubMed ID: 2341265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ON SOME INDICES OF THE BLOOD COAGULATION AND ANTICOAGULATION SYSTEM IN PATIENTS WITH MYOCARDIAL INFARCT AND CORONARY INSUFFICIENCY].
    KONIAEV BV; RUBNEVA PA; VIUSHINA OP; NEKLIUDOVA VI; SYCHEVA IK
    Kardiologiia; 1964; 4():16-22. PubMed ID: 14152583
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J
    J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.